Evidence map›Paper›PMID 31707037›Full record

ReviewPharmacological research2020

Megalin: A bridge connecting kidney, the renin-angiotensin system, and atherosclerosis.

Masayoshi Kukida, Hisashi Sawada, Alan Daugherty, Hong S Lu

Open access · greenAbstract readReview
In one paragraph

Review in Pharmacological research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Internalization of Angiotensin-(1-12) in Adult Retinal Pigment Epithelial-19 Cells.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Masayoshi KukidaSaha Cardiovascular Research Center and Department of Physiology, University of Kentucky, Lexington, KY, USA.
Hisashi SawadaSaha Cardiovascular Research Center and Department of Physiology, University of Kentucky, Lexington, KY, USA.
Alan DaughertySaha Cardiovascular Research Center and Department of Physiology, University of Kentucky, Lexington, KY, USA.
Hong S LuSaha Cardiovascular Research Center and Department of Physiology, University of Kentucky, Lexington, KY, USA. Electronic address: Hong.Lu@uky.edu.
University of Kentucky · US

Funding

Adventitial-medial interactions in thoracic aortic diseasesR01HL133723 · NHLBI · UNIVERSITY OF KENTUCKY · PI DAUGHERTY, ALAN · 2016 to 2019
$2.9M
Atherosclerosis Mechanisms: Angiotensin II production and actionR01HL139748 · NHLBI · UNIVERSITY OF KENTUCKY · PI DAUGHERTY, ALAN, LU, HONG SHEN · 2018 to 2021
$2.0M
NHLBI NIH HHS R01 HL133723NHLBI NIH HHS R01 HL139748
6 · The paper itself

Abstract

Megalin is a member of the low-density lipoprotein receptor superfamily. It has been recognized as an endocytic receptor for a large spectrum of ligands. As a consequence, megalin regulates homeostasis of many molecules and affects multiple physiological and pathophysiological functions. The renin-angiotensin system is a hormonal system. A number of studies have reported contributions of the renin-angiotensin system to atherosclerosis. There is evolving evidence that megalin is a regulator of the renin-angiotensin system, and contributes to atherosclerosis. This brief review provides contemporary insights into effects of megalin on renal functions, the renin-angiotensin system, and atherosclerosis.

Indexed as

Renin-Angiotensin SystemAnimalsAtherosclerosisHumansKidneyKidney DiseasesLow Density Lipoprotein Receptor-Related Protein-2MutationLow Density Lipoprotein Receptor-Related Protein-2AtherosclerosisKidneyMegalinRenin angiotensin system

Identifiers

PMID31707037
PMCPMC6980733
OpenAlexW2988919005

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.